Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
deferiprone (ferriprox) (1 trial)
deferoxamine (desferal) (1 trial)
beta-Thalassemia (Phase 4)
Cardiomyopathies (Phase 4)
Heart Diseases (Phase 4)
Iron Overload (Phase 4)
Thalassemia (Phase 4)
Trials (1 total)
Trial APIs (2 total)